Literature DB >> 26408183

MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma.

Bin Chen1,2, Wenyan Pan3, Xiaoxi Lin4, Zhenzhen Hu5, Yunbo Jin4, Hui Chen4, Gang Ma4, Yajing Qiu4, Lei Chang4, Chen Hua4, Yun Zou4, Yang Gao4, Hanru Ying4, Dongze Lv4.   

Abstract

Cutaneous squamous cell carcinoma (cSCC) is an epidermal keratinocyte-derived skin tumor, which is the second most common skin cancer in the general population. Recently, studies showed that microRNAs (miRNAs) played an important role in the development of cancer. In our study, we showed that the expression of SRCIN1 was lower in cSCC tissues than in the matched normal tissues. Moreover, there was significant inversed correlation between miR-346 and SRCIN1 in cSCC tissues. The luciferase reporter assay data showed that miR-346 can target the SRCIN1 message via the 3'-untranslated region (UTR) of SRCIN1. Overexpression of miR-346 inhibited the messenger RNA (mRNA) and protein expression of SRCIN1 in the A431 cells. In addition, ectopic expression of miR-346 promoted the A431 cell proliferation and migration. Meanwhile, SRCIN1 overexpression inhibited the A431 cell proliferation and migration. Rescue experiment has showed that SRCIN1 overexpression reduced the miR-346-induced A431 cell proliferation and migration. Herein, this study may provide miR-346 as a new therapeutic target for cSCC.

Entities:  

Keywords:  Cutaneous squamous cell carcinoma; Oncogene; SRCIN1; miR-346

Mesh:

Substances:

Year:  2015        PMID: 26408183     DOI: 10.1007/s13277-015-4046-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  43 in total

1.  Effects of microRNA-346 on epithelial-mesenchymal transition in mouse podocytes.

Authors:  Jing Xiao; Dong Liu; Wenju Jiao; Jia Guo; Xiaoyang Wang; Xiaoxue Zhang; Shan Lu; Zhanzheng Zhao
Journal:  Gene       Date:  2015-02-04       Impact factor: 3.688

2.  MiR-346 regulates CD4⁺CXCR5⁺ T cells in the pathogenesis of Graves' disease.

Authors:  Juan Chen; Jie Tian; Xinyi Tang; Ke Rui; Jie Ma; Chaoming Mao; Yingzhao Liu; Liwei Lu; Huaxi Xu; Shengjun Wang
Journal:  Endocrine       Date:  2015-02-11       Impact factor: 3.633

3.  miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.

Authors:  Minghui Cao; Dongxia Hou; Hongwei Liang; Fei Gong; Yilei Wang; Xin Yan; Xiaohong Jiang; Chen Wang; Junfeng Zhang; Ke Zen; Chen-Yu Zhang; Xi Chen
Journal:  Eur J Cancer       Date:  2014-01-20       Impact factor: 9.162

4.  Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.

Authors:  Keitaro Yamane; Masatoshi Jinnin; Tomomi Etoh; Yuki Kobayashi; Naoki Shimozono; Satoshi Fukushima; Shinichi Masuguchi; Keishi Maruo; Yuji Inoue; Tsuyoshi Ishihara; Jun Aoi; Yuichi Oike; Hironobu Ihn
Journal:  J Mol Med (Berl)       Date:  2012-07-25       Impact factor: 4.599

5.  MicroRNA-346 mediates tumor necrosis factor α-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases.

Authors:  Yunzi Chen; Jie Du; Zhongyi Zhang; Tianjing Liu; Yongyan Shi; Xin Ge; Yan Chun Li
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

Review 6.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

7.  MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells.

Authors:  Aoxue Wang; Ning Xu Landén; Florian Meisgen; Warangkana Lohcharoenkal; Mona Ståhle; Enikö Sonkoly; Andor Pivarcsi
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

8.  Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.

Authors:  Bo-sheng Li; Yong-liang Zhao; Gang Guo; Wei Li; En-dong Zhu; Xiao Luo; Xu-hu Mao; Quan-ming Zou; Pei-wu Yu; Qian-fei Zuo; Na Li; Bin Tang; Kai-yun Liu; Bin Xiao
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

9.  miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma.

Authors:  Soumya Alige Mahabala Rao; Arivazhagan Arimappamagan; Paritosh Pandey; Vani Santosh; Alangar Sathyaranjandas Hegde; Bangalore Ashwathnarayanara Chandramouli; Kumaravel Somasundaram
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

10.  Mapping of p140Cap phosphorylation sites: the EPLYA and EGLYA motifs have a key role in tyrosine phosphorylation and Csk binding, and are substrates of the Abl kinase.

Authors:  Daniele Repetto; Simona Aramu; Elisabetta Boeri Erba; Nanaocha Sharma; Silvia Grasso; Isabella Russo; Ole N Jensen; Sara Cabodi; Emilia Turco; Paola Di Stefano; Paola Defilippi
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more
  18 in total

1.  MicroRNA-346 regulates neural stem cell proliferation and differentiation by targeting KLF4.

Authors:  Xingyu Miao; Xiaoying Wu; Wei Shi
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  MiR-217 promotes cutaneous squamous cell carcinoma progression by targeting PTRF.

Authors:  Ming Bai; Mingzi Zhang; Fei Long; Nanze Yu; Ang Zeng; Xiaojun Wang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

3.  miRNA-346 promotes proliferation, migration and invasion in liver cancer.

Authors:  Qiang Yu; Xia Yang; Weidong Duan; Chonghui Li; Ying Luo; Shichun Lu
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

4.  A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer.

Authors:  Peide Huang; Fengyu Li; Zongchao Mo; Chunyu Geng; Fang Wen; Chunyan Zhang; Jia Guo; Song Wu; Lin Li; Nils Brünner; Jan Stenvang
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

5.  MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway.

Authors:  Cheng-Cao Sun; Shu-Jun Li; Zhan-Peng Yuan; De-Jia Li
Journal:  Aging (Albany NY)       Date:  2016-10-18       Impact factor: 5.682

6.  Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice.

Authors:  Alberto Izzotti; Roumen Balansky; Gancho Ganchev; Marietta Iltcheva; Mariagrazia Longobardi; Alessandra Pulliero; Marta Geretto; Rosanna T Micale; Sebastiano La Maestra; Mark Steven Miller; Vernon E Steele; Silvio De Flora
Journal:  Oncotarget       Date:  2016-12-20

7.  The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.

Authors:  Silvia Grasso; Jennifer Chapelle; Vincenzo Salemme; Simona Aramu; Isabella Russo; Nicoletta Vitale; Ludovica Verdun di Cantogno; Katiuscia Dallaglio; Isabella Castellano; Augusto Amici; Giorgia Centonze; Nanaocha Sharma; Serena Lunardi; Sara Cabodi; Federica Cavallo; Alessia Lamolinara; Lorenzo Stramucci; Enrico Moiso; Paolo Provero; Adriana Albini; Anna Sapino; Johan Staaf; Pier Paolo Di Fiore; Giovanni Bertalot; Salvatore Pece; Daniela Tosoni; Stefano Confalonieri; Manuela Iezzi; Paola Di Stefano; Emilia Turco; Paola Defilippi
Journal:  Nat Commun       Date:  2017-03-16       Impact factor: 14.919

8.  In silico identification of microRNAs predicted to regulate N-myristoyltransferase and Methionine Aminopeptidase 2 functions in cancer and infectious diseases.

Authors:  Ranjit Chauhan; David Datzkiw; Shailly Varma Shrivastav; Anuraag Shrivastav
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

9.  Prognostic values of YTHDF1 regulated negatively by mir-3436 in Glioma.

Authors:  Chenyang Xu; Bingjian Yuan; Tao He; Bingqian Ding; Song Li
Journal:  J Cell Mol Med       Date:  2020-05-25       Impact factor: 5.310

10.  MiR-346 suppresses cell proliferation through SMYD3 dependent approach in hepatocellular carcinoma.

Authors:  Weiyou Zhu; Jing Qian; Ling Ma; Pei Ma; Fengming Yang; Yongqian Shu
Journal:  Oncotarget       Date:  2017-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.